key: cord-0744878-1i9pjagh
authors: Said, Jordan T.; Virgen, Cesar A.; Lian, Christine G.; Cutler, Corey S.; Merola, Joseph F.; LeBoeuf, Nicole R.
title: Disseminated Varicella-Zoster Virus Infections Following mRNA-Based COVID-19 Vaccination
date: 2021-09-20
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.09.008
sha: 079e9ecd02d2e57ee78a6a1c60dd4455974b3877
doc_id: 744878
cord_uid: 1i9pjagh

nan

for important intellectual content. All provided final approval of the manuscript and agree to be 31 accountable for all aspects of the work. Delayed localized hypersensitive reactions have also been reported, but these do not preclude 61 subsequent vaccination, emphasizing that serious cutaneous reactions to the vaccines are rare. 3 We 62 report two cases of de novo disseminated varicella-zoster virus (VZV) infection, without expansion from a 63 preceding dermatomal presentation, after receiving an mRNA-based COVID-19 vaccine in patients who 64

were not actively on immunosuppression. 

Safety and Efficacy of the BNT162b2 mRNA Covid-19

Cutaneous Reactions Reported after Moderna 172 and Pfizer COVID-19 Vaccination: A Registry-Based Study of 414 Cases

Delayed Localized Hypersensitivity Reactions to the 175

Moderna COVID-19 Vaccine

mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case 179 series

Varicella zoster virus reactivation and 181 mRNA vaccines as a trigger

SARS-CoV-2 vaccination. JAAD Case Reports

Public Health Service (PHS) C 185 for DC (CDC) / F and DA (FDA). Vaccine Adverse Event Reporting System

Reactivation of herpesvirus infections 188 after vaccinations? Lancet

Presumed Herpes Zoster Ophthalmicus 190

Reactivation Following Recombinant Zoster Vaccination. Cornea

20 Post-COVID-19 vaccine-related shingles cases seen 194 at the Las Vegas Dermatology clinic and sent to us via social media